We recommend setting up a follow-up appointment to discuss your progress and to make any necessary adjustments
Become a member online and schedule your lab appointment immediately
I am not an attorney and I do not represent the FDA, Novo Nordisk, or Eli Lillynor do I speak on their behalf. Editors Note (Updated June 2025): We updated this article to reflect the FDAs latest actions and expert guidance on compounded GLP-1s
Doctors need to watch patients on GLP-1 for signs of gastroparesis
Retatrutide 30 mg Third-Party Test Results Manufacturer: LeoLab Sample: Retatrutide 30 mg Batch: G60319 Test Date: 17 June 2025 Testing Laboratory: Janoshik Analytical Task Number: 68250 In this latest independent analysis, a sample of Retatrutide 30 mg was submitted to Janoshik Analytical , a well-respected third-party testing facility known for its precision in peptide verification
That makes it mechanistically independent of appetite or metabolic rate, which is the basis for the article's argument that the two drugs target different pathways